ISRCTN80857707已完成不适用
The effect of omega-3 polyunsaturated fatty acid dose level on hyperpnoea-induced bronchoconstriction and markers of airway inflammation in asthma
ottingham Trent University (UK)0 个研究点目标入组 108 人开始时间: 2016年5月13日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 108
研究概览
简要总结
2017 results in https://www.ncbi.nlm.nih.gov/pubmed/28606216
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- Male
入选标准
- •1. Body mass index (BMI) 20-25 kg.m-2
- •2. Physically active 3 or more times a week , with each exercise session lasting at least 45 min
- •3. Non-smoker
- •4. Non-vegetarian or vegan
- •5. Asthma sufferers must have own clinically prescribed medication
- •6. Asthma sufferers must have a GP diagnosis
排除标准
- •1. Predicted forced expiratory volume in 1 second (FEV1) less than 65%
- •2. Previously diagnosed with COPD, emphysema, chronic bronchitis or similar respiratory illness
- •3. Previously admitted to hospital for asthma or other breathing difficulties
- •4. Asthma exacerbation within the last month (course of steroids or hospital visit)
- •5. History of heart failure, pulmonary hypertension, embolism, or other pulmonary heart disease
- •6. History of recurrent chest infections
- •8. Acute infection within the last four weeks
- •9. Major operation within the past four months
- •10. Have a history of taking ?-3 PUFA supplements or supplements with antioxidants above recommended intake, or consume more than three fatty fish meals per week
- •11. Take a daily dose of aspirin or other NSAIDs
- •12. Currently taking a daily dose of anti-histamine
- •13. Currently taking long-term asthma maintenance medications – corticosteroids, and leukotriene modifiers that you could not refrain from taking for 4 days prior to laboratory session
研究者
相似试验
已完成
不适用
Evaluation of the effect of supplementation with omega-3 fatty acids and vitamin D on blood sugar, lipids, cholesterol and inflammation markers, and body weight, in patients with diabetes mellitusType 2 Diabetes MellitusISRCTN97792326niversidad Autonoma del Estado de Mexico120
已完成
2 期
The effect of omega 3 polyunsaturated fatty acid supplementation on inflammatory markers and insulin resistanse factors in patients with Type 2 Diabetes and Nonalcoholic Fatty Liver DiseaseCondition 1: type 2 diabetes. Condition 2: Nonalcoholic fatty liver disease (NAFLD).Non-insulin-dependent diabetes mellitusFatty (change of) liver, not elsewhere classified (NAFLD)IRCT2017103030489N2Yazd Shahid Sadoughi University of Medical Sciences48
已完成
2 期
Effect of omega-3 fatty acid supplementation in patients with Type 2 Diabetes and Nonalcoholic Fatty Liver Disease.Condition 1: type 2 diabetes. Condition 2: Nonalcoholic fatty liver disease (NAFLD).Non-insulin-dependent diabetes mellitusFatty (change of) liver, not elsewhere classified (NAFLD)IRCT2016102530489N1Yazd Shahid Sadoughi University of Medical Sciences60
已完成
不适用
The influence of ingesting fish oil during two weeks of weight loss on changes in body mass and muscle strengthISRCTN14254471Smartfish Nutrition Ltd.20
已完成
不适用
The effect of omega-3 in the prevention of cardiac complications after PCIChronic ischaemic heart disease.Atherosclerotic heart diseaseIRCT2016072329035N1Ardabil University of Medical Sciences100